Elanco Animal Health (ELAN) Receivables - Net (2017 - 2026)
Elanco Animal Health (ELAN) posted Receivables - Net of $1.1 billion for Q1 2026, up 24.17% sequentially from $873.0 million in Q4 2025, and up 11.75% YoY from $970.0 million in Q1 2025.
Elanco Animal Health (ELAN) Receivables - Net (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Receivables - Net for 10 years, with the latest figure at $1.1 billion in Q1 2026.
- Quarterly Receivables - Net rose 11.75% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 11.75% YoY) and the FY2025 annual result came in at $873.0 million, up 8.45% from the prior year.
- Receivables - Net rose to $1.1 billion in Q1 2026 per ELAN's latest filing, from $873.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $1.1 billion in Q1 2026 and troughed at $797.0 million in Q4 2022.
- A 5-year average of $925.6 million and a median of $916.0 million in 2022 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net fell 14.15% in 2022, then grew 13.31% in 2023.
- Over 5 years, Receivables - Net stood at $797.0 million in 2022, then rose by 5.65% to $842.0 million in 2023, then decreased by 4.39% to $805.0 million in 2024, then climbed by 8.45% to $873.0 million in 2025, then grew by 24.17% to $1.1 billion in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $1.1 billion, $873.0 million, and $894.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 Bn |
| Jun 30, 2026 | 1.08 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 873.00 Mn |
| Dec 31, 2025 | 873.00 Mn |
| Sep 30, 2025 | 894.00 Mn |
| Sep 30, 2025 | 894.00 Mn |
| Jun 30, 2025 | 989.00 Mn |
| Jun 30, 2025 | 989.00 Mn |
| Mar 31, 2025 | 970.00 Mn |
| Mar 31, 2025 | 970.00 Mn |
| Dec 31, 2024 | 805.00 Mn |
| Dec 31, 2024 | 805.00 Mn |
| Sep 30, 2024 | 840.00 Mn |
| Sep 30, 2024 | 840.00 Mn |
| Jun 30, 2024 | 999.00 Mn |
| Jun 30, 2024 | 999.00 Mn |
| Mar 31, 2024 | 988.00 Mn |
| Mar 31, 2024 | 988.00 Mn |